SG11201401693UA - Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them - Google Patents

Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them

Info

Publication number
SG11201401693UA
SG11201401693UA SG11201401693UA SG11201401693UA SG11201401693UA SG 11201401693U A SG11201401693U A SG 11201401693UA SG 11201401693U A SG11201401693U A SG 11201401693UA SG 11201401693U A SG11201401693U A SG 11201401693UA SG 11201401693U A SG11201401693U A SG 11201401693UA
Authority
SG
Singapore
Prior art keywords
baclofen
memantine
pharmaceutical composition
composition containing
therapeutic combination
Prior art date
Application number
SG11201401693UA
Other languages
English (en)
Inventor
Péter Kovács
Tamás Kitka
Melinda Misnyovszki
Balázs Varga
Sándor Farkas
Csilla Mária Horváth
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of SG11201401693UA publication Critical patent/SG11201401693UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201401693UA 2011-11-07 2012-11-06 Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them SG11201401693UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1100615A HU230263B1 (hu) 2011-11-07 2011-11-07 Memantin és baclofen hatóanyagokat tartalmazó kombinációs készítmény
PCT/HU2012/000119 WO2013068774A1 (en) 2011-11-07 2012-11-06 Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them

Publications (1)

Publication Number Publication Date
SG11201401693UA true SG11201401693UA (en) 2014-05-29

Family

ID=89990495

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401693UA SG11201401693UA (en) 2011-11-07 2012-11-06 Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them

Country Status (23)

Country Link
US (1) US20140316007A1 (enrdf_load_stackoverflow)
EP (1) EP2776019A1 (enrdf_load_stackoverflow)
JP (1) JP2014532752A (enrdf_load_stackoverflow)
KR (1) KR20140090203A (enrdf_load_stackoverflow)
CN (1) CN103930099A (enrdf_load_stackoverflow)
AU (1) AU2012335358A1 (enrdf_load_stackoverflow)
BR (1) BR112014010892A2 (enrdf_load_stackoverflow)
CA (1) CA2853872A1 (enrdf_load_stackoverflow)
CL (1) CL2014001167A1 (enrdf_load_stackoverflow)
CO (1) CO6970599A2 (enrdf_load_stackoverflow)
CR (1) CR20140264A (enrdf_load_stackoverflow)
CU (1) CU20140052A7 (enrdf_load_stackoverflow)
EA (1) EA201490935A1 (enrdf_load_stackoverflow)
HK (1) HK1200101A1 (enrdf_load_stackoverflow)
HU (1) HU230263B1 (enrdf_load_stackoverflow)
IL (1) IL232232A0 (enrdf_load_stackoverflow)
IN (1) IN2014KN01142A (enrdf_load_stackoverflow)
MX (1) MX2014005499A (enrdf_load_stackoverflow)
NI (1) NI201400039A (enrdf_load_stackoverflow)
PE (1) PE20141576A1 (enrdf_load_stackoverflow)
PH (1) PH12014500979A1 (enrdf_load_stackoverflow)
SG (1) SG11201401693UA (enrdf_load_stackoverflow)
WO (1) WO2013068774A1 (enrdf_load_stackoverflow)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040102525A1 (en) * 2002-05-22 2004-05-27 Kozachuk Walter E. Compositions and methods of treating neurological disease and providing neuroprotection
CN101500610A (zh) * 2006-08-11 2009-08-05 国立大学法人名古屋大学 抗肥胖药及其利用
US20100197789A1 (en) * 2006-08-11 2010-08-05 National University Corporation Nagoya University Anti-obesity agent and use thereof

Also Published As

Publication number Publication date
CO6970599A2 (es) 2014-06-13
NI201400039A (es) 2014-10-02
EP2776019A1 (en) 2014-09-17
HK1200101A1 (en) 2015-07-31
PH12014500979A1 (en) 2014-06-09
WO2013068774A1 (en) 2013-05-16
KR20140090203A (ko) 2014-07-16
US20140316007A1 (en) 2014-10-23
CU20140052A7 (es) 2014-07-30
CA2853872A1 (en) 2013-05-16
MX2014005499A (es) 2015-02-20
IL232232A0 (en) 2014-06-30
PE20141576A1 (es) 2014-11-06
HU230263B1 (hu) 2015-11-30
HUP1100615A2 (en) 2013-06-28
AU2012335358A1 (en) 2014-05-29
CL2014001167A1 (es) 2014-07-04
EA201490935A1 (ru) 2014-08-29
BR112014010892A2 (pt) 2017-06-13
IN2014KN01142A (enrdf_load_stackoverflow) 2015-10-16
CN103930099A (zh) 2014-07-16
JP2014532752A (ja) 2014-12-08
CR20140264A (es) 2014-07-11

Similar Documents

Publication Publication Date Title
IL265707A (en) Pharmaceutical preparations containing human antibodies to pcsk9
PL3378862T3 (pl) Dihydropirymidynoizochinolinony i ich kompozycie farmaceutyczne do leczenia stwardnienia rozsianego
IL239557B (en) Microarray for providing therapeutic material and methods for use
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
ZA201505849B (en) Composition of novel carbohydrate drug for treatment of human diseases
IL230463A0 (en) Benzamides, their preparation and pharmaceutical preparations containing them
GB201302653D0 (en) Pharmaceutical compositions and methods of treatment
SI2691083T1 (sl) Farmacevtski sestavek sitagliptina
IL235831A0 (en) A new dosage form and formulation of aveditrol
IL237139A0 (en) Pharmaceutical compositions of memantine
ZA201402820B (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
IL232434B (en) Medicine for medical treatment and/or improvement of sepsis
ZA201306905B (en) Novel octahydrothienoquinonline derivative,pharmaceutical composition comprising derivative, and use of these
SG11201401038VA (en) Isolating and therapeutic use of perivascular medicinal cells
GB2490671B (en) Dosage Unit for Administration of Antibiotics to the Small and Large Intestine
HRP20180781T1 (hr) Farmaceutski pripravak koji sadržava lidipidipin i proces pripreme
IL232232A0 (en) A therapeutic combination of memantine and baclofen and a pharmaceutical preparation containing them
ZA201205978B (en) Solid pharmaceutical composition for buccal administration of agomelatine
IL256992B (en) Baclofen and acamprosate based therapy of neurogical disorders
GB201104632D0 (en) Use of medicament
GB201112739D0 (en) Production and administration of therapeutic agents
GB201112578D0 (en) Pharmaceutical preparation and use
PT3326648T (pt) Composições farmacêuticas que compreendem anticorpos humanos para pcsk9
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds
AU2011900519A0 (en) Drug compositions for the treatment of insomnia